U.S. Markets close in 6 hrs 11 mins

Factors of Influence in 2019, Key Indicators and Opportunity within Wright Medical Group N.V, MSA Safety Incorporporated, Minerva Neurosciences, OSI, Argan, and Approach Resources — New Research Emphasizes Economic Growth

NEW YORK, Feb. 05, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Wright Medical Group N.V. (WMGI), MSA Safety Incorporporated (MSA), Minerva Neurosciences, Inc (NERV), OSI Systems, Inc. (OSIS), Argan, Inc. (AGX), and Approach Resources Inc. (AREX), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

WMGI DOWNLOAD: http://Capital-Review.com/register/?so=WMGI
MSA DOWNLOAD: http://Capital-Review.com/register/?so=MSA
NERV DOWNLOAD: http://Capital-Review.com/register/?so=NERV
OSIS DOWNLOAD: http://Capital-Review.com/register/?so=OSIS
AGX DOWNLOAD: http://Capital-Review.com/register/?so=AGX
AREX DOWNLOAD: http://Capital-Review.com/register/?so=AREX

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Capital Review, available for free download at the links above, examine Wright Medical Group N.V. (WMGI), MSA Safety Incorporporated (MSA), Minerva Neurosciences, Inc (NERV), OSI Systems, Inc. (OSIS), Argan, Inc. (AGX), and Approach Resources Inc. (AREX) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed February 1st, 2019. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

WRIGHT MEDICAL GROUP N.V. (WMGI) REPORT OVERVIEW

Wright Medical Group N.V's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Wright Medical Group N.V reported revenue of $194.11MM vs $170.50MM (up 13.84%) and analysts estimated basic earnings per share -$0.38 vs -$1.26. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Wright Medical Group N.V reported revenue of $744.99MM vs $690.36MM (up 7.91%) and analysts estimated basic earnings per share -$1.94 vs -$4.20. Analysts expect earnings to be released on February 26th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.10. The estimated EPS forecast for the next fiscal year is $0.23 and is expected to report on February 26th, 2019.

To read the full Wright Medical Group N.V. (WMGI) report, download it here: http://Capital-Review.com/register/?so=WMGI

-----------------------------------------

MSA SAFETY INCORPORPORATED (MSA) REPORT OVERVIEW

MSA Safety Incorporporated's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, MSA Safety Incorporporated reported revenue of $331.10MM vs $296.13MM (up 11.81%) and analysts estimated basic earnings per share $0.88 vs $0.84 (up 4.76%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, MSA Safety Incorporporated reported revenue of $1,196.81MM vs $1,149.53MM (up 4.11%) and analysts estimated basic earnings per share $0.68 vs $2.45 (down 72.24%). Analysts expect earnings to be released on February 19th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $1.35. The estimated EPS forecast for the next fiscal year is $4.90 and is expected to report on February 19th, 2019.

To read the full MSA Safety Incorporporated (MSA) report, download it here: http://Capital-Review.com/register/?so=MSA

-----------------------------------------

MINERVA NEUROSCIENCES, INC (NERV) REPORT OVERVIEW

Minerva Neurosciences' Recent Financial Performance

Analysts expect earnings to be released on March 11th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was -$0.24. The estimated EPS forecast for the next fiscal year is -$1.48 and is expected to report on March 11th, 2019.

To read the full Minerva Neurosciences, Inc (NERV) report, download it here: http://Capital-Review.com/register/?so=NERV

-----------------------------------------

OSI SYSTEMS, INC. (OSIS) REPORT OVERVIEW

OSI's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, OSI reported revenue of $303.21MM vs $277.53MM (up 9.25%) and basic earnings per share $1.06 vs -$2.47. For the twelve months ended June 30th, 2018 vs June 30th, 2017, OSI reported revenue of $1,089.29MM vs $960.95MM (up 13.35%) and analysts estimated basic earnings per share -$1.57 vs $1.12. Analysts expect earnings to be released on April 25th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.86. The estimated EPS forecast for the next fiscal year is $4.21 and is expected to report on August 22nd, 2019.

To read the full OSI Systems, Inc. (OSIS) report, download it here: http://Capital-Review.com/register/?so=OSIS

-----------------------------------------

ARGAN, INC. (AGX) REPORT OVERVIEW

Argan's Recent Financial Performance

For the three months ended October 31st, 2018 vs October 31st, 2017, Argan reported revenue of $116.46MM vs $232.95MM (down 50.01%) and analysts estimated basic earnings per share $2.08 vs $1.11 (up 87.39%). For the twelve months ended January 31st, 2018 vs January 31st, 2017, Argan reported revenue of $892.82MM vs $675.05MM (up 32.26%) and analysts estimated basic earnings per share $4.64 vs $4.67 (down 0.64%). Analysts expect earnings to be released on April 10th, 2019. The report will be for the fiscal period ending January 31st, 2019.

To read the full Argan, Inc. (AGX) report, download it here: http://Capital-Review.com/register/?so=AGX

-----------------------------------------

APPROACH RESOURCES INC. (AREX) REPORT OVERVIEW

Approach Resources' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Approach Resources reported revenue of $32.56MM vs $25.61MM (up 27.16%) and analysts estimated basic earnings per share -$0.05 vs -$0.10. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Approach Resources reported revenue of $105.35MM vs $90.30MM (up 16.66%) and analysts estimated basic earnings per share -$1.35 vs -$1.26. Analysts expect earnings to be released on March 14th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$0.07. The estimated EPS forecast for the next fiscal year is -$0.28 and is expected to report on March 14th, 2019.

To read the full Approach Resources Inc. (AREX) report, download it here: http://Capital-Review.com/register/?so=AREX

-----------------------------------------

ABOUT CAPITAL REVIEW

Capital Review is a nationally recognized publisher of financial analysis, research reports, and exclusive market reporting. Institutional investors, registered brokers, professional traders, and personal investment advisers rely on Capital Review to quantify public company valuations, discover opportunity across asset classes, stay informed about market-moving events, and read exclusive analysis of important material developments. With 14 offices worldwide, Capital Review staffs and manages certified and registered financial professionals, including Chartered Financial Analyst® (CFA®) designation holders and FINRA® BrokerCheck® certified individuals with current and valid CRD® number designations, to enable continuous coverage of topics relevant to its regular active reader base.

REGISTERED MEMBER STATUS

Capital Review's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Capital Review's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Capital Review have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Capital Review's Compliance department by Phone, at +1 (410) 280-7496, or by E-mail at compliance@Capital-Review.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Capital Review, Capital Review members, and/or Capital Review affiliates are not responsible for any gains or losses that result from the opinions expressed. Capital Review makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Capital Review has not been compensated for the publication of this press release by any of the above mentioned companies. Capital Review is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Nicole Garrens, Media Department
Office: +1 (410) 280-7496
E-mail: media@Capital-Review.com

© 2019 Capital Review. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Capital-Review.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.